1.
Pharmacoeconomic aspects of warfarin and new oral anticoagulants use as prevention of thromboembolic complications in patients with atrial fibrillation. UJC [Internet]. 2020 Oct. 1 [cited 2024 Jun. 15];27(4):45-53. Available from: https://ucardioj.com.ua/index.php/UJC/article/view/229